These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16645446)

  • 1. Geographic regional differences in rocuronium bromide dose-response relation and time course of action: an overlooked factor in determining recommended dosage.
    Dahaba AA; Perelman SI; Moskowitz DM; Bennett HL; Shander A; Xiao Z; Huang L; An G; Bornemann H; Wilfinger G; Hager B; Rehak PH; List WF; Metzler H
    Anesthesiology; 2006 May; 104(5):950-3. PubMed ID: 16645446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No regional difference in cisatracurium dose-response and time-course-of-action between patients in China and Bosnia.
    Dahaba AA; Suljevic I; Bornemann H; Wu XM; Metzler H
    Br J Anaesth; 2011 Mar; 106(3):331-5. PubMed ID: 21205623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the dose-response and time course of action of rocuronium and vecuronium in anesthetized adult patients.
    Xue FS; Liao X; Liu JH; Tong SY; Zhang YM; Zhang RJ; An G; Luo LK
    J Clin Anesth; 1998 Aug; 10(5):410-5. PubMed ID: 9702623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-response of rocuronium bromide in children anesthetized with propofol: a comparison with succinylcholine.
    Woolf RL; Crawford MW; Choo SM
    Anesthesiology; 1997 Dec; 87(6):1368-72. PubMed ID: 9416722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of acute normovolaemic haemodilution on the dose-response relationship, time-course of action and pharmacokinetics of rocuronium bromide.
    Dahaba AA; Perelman SI; Moskowitz DM; Bennett HL; Shander A; Oettl K; Reibnegger G; Metzler H
    Br J Anaesth; 2006 Oct; 97(4):482-8. PubMed ID: 16873389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of the dose-response and time course of recovery of atracurium and rocuronium.
    Xue F; Zhang Y; Liao X; Liu J; An G
    Chin Med J (Engl); 2000 Nov; 113(11):1019-21. PubMed ID: 11776116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mindray 3-directional NMT Module (a new generation "Tri-axial" neuromuscular monitor) versus the Relaxometer mechanomyograph and versus the TOF-Watch SX acceleromyograph.
    Dahaba AA; Suljevic I; Xiao ZY; Wang K
    J Clin Monit Comput; 2019 Oct; 33(5):853-862. PubMed ID: 30519895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of gender on the potency and course of action of rocuronium bromide].
    Steinberg D
    Rev Esp Anestesiol Reanim; 2009 Dec; 56(10):604-11. PubMed ID: 20151522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response relationship of rocuronium bromide during intravenous anaesthesia.
    Mellinghoff H; Diefenbach C; Bischoff A; Grond S; Buzello W
    Eur J Anaesthesiol Suppl; 1994; 9():20-4. PubMed ID: 7925204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response and time course of effect of rocuronium in male and female anesthetized patients.
    Xue FS; Tong SY; Liao X; Liu JH; An G; Luo LK
    Anesth Analg; 1997 Sep; 85(3):667-71. PubMed ID: 9296428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prolonged duration of rocuronium in Chinese patients.
    Collins LM; Bevan JC; Bevan DR; Villar GC; Kahwaji R; Smith MF; Donati F
    Anesth Analg; 2000 Dec; 91(6):1526-30. PubMed ID: 11094012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade.
    Naguib M; Abdulatif M; al-Ghamdi A
    Anesthesiology; 1993 Oct; 79(4):739-45. PubMed ID: 8214753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular blocking effects of rocuronium during desflurane, isoflurane, and sevoflurane anaesthesia.
    Wulf H; Ledowski T; Linstedt U; Proppe D; Sitzlack D
    Can J Anaesth; 1998 Jun; 45(6):526-32. PubMed ID: 9669005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromuscular effects of rocuronium bromide and mivacurium chloride administered alone and in combination.
    Naguib M
    Anesthesiology; 1994 Aug; 81(2):388-95. PubMed ID: 8053589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ED
    Chen IY; Sugita C; Wei Y; Daimaruya N; Itami T; Sano T; Yamashita K
    Vet Anaesth Analg; 2023 May; 50(3):204-210. PubMed ID: 36967325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potency and recovery characteristics of rocuronium mixed with sodium bicarbonate.
    Lee HJ; Kim KS; Yeon JT; Suh JK; Sung IH; Shin IC
    Anaesthesia; 2010 Sep; 65(9):899-903. PubMed ID: 20608923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of sugammadex in the reversal of neuromuscular blockade induced by rocuronium in long-duration surgery: under inhaled vs. intravenous anesthesia].
    Veiga-Ruiz G; Domínguez N; Orozco J; Janda M; Hofmockel R; Alvarez-Gómez JA
    Rev Esp Anestesiol Reanim; 2009; 56(6):349-54. PubMed ID: 19725342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rocuronium 0.3 mg x kg-1 (ED95) induces a normal peak effect but an altered time course of neuromuscular block in patients with Duchenne's muscular dystrophy.
    Muenster T; Schmidt J; Wick S; Forst J; Schmitt HJ
    Paediatr Anaesth; 2006 Aug; 16(8):840-5. PubMed ID: 16884467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative potency of steroidal neuromuscular blocking drugs and isobolographic analysis of the interaction between rocuronium and other aminosteroids.
    Naguib M; Samarkandi AH; Bakhamees HS; Magboul MA; el-Bakry AK
    Br J Anaesth; 1995 Jul; 75(1):37-42. PubMed ID: 7669466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.